Century Therapeutics
IPSC
IPSC
70 hedge funds and large institutions have $14.1M invested in Century Therapeutics in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 29 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
-2
Holders Change %
-2.78%
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
7
Increased
16
Reduced
29
Closed
8
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
-$2K
Top Buyers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$66.9K |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$41.4K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$29K |
| 4 |
Goldman Sachs
New York
|
+$18.1K |
| 5 |
Two Sigma Advisers
New York
|
+$12.3K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$1.62M |
| 2 |
CC
Casdin Capital
New York
|
-$942K |
| 3 |
VA
VR Adviser
New York
|
-$695K |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$265K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$243K |
